245 filings
Page 2 of 13
SC TO-T/A
294370fby
27 Dec 21
Third party tender offer statement (amended)
8:08am
SC 14D9/A
5omvxi5yg u9tk453
27 Dec 21
Tender offer solicitation (amended)
8:00am
SC 14D9/A
zrfwdsaz78tvgkvx2m
15 Dec 21
Tender offer solicitation (amended)
8:30am
SC TO-T/A
flx ysdavjl
8 Dec 21
Third party tender offer statement (amended)
8:28am
SC 14D9/A
kuro1uejx8k6aamk
8 Dec 21
Tender offer solicitation (amended)
7:30am
SC 14D9
kvt4ecxhf f9u4ief
24 Nov 21
Tender offer solicitation
5:06pm
SC TO-T
5b3f55xc2l 9tz2wr
24 Nov 21
Third party tender offer statement
4:57pm
SC TO-C
za25ovqibccz16 dez0g
18 Nov 21
Information about tender offer
5:31pm
SC14D9C
7g9b 3d6m
18 Nov 21
Written communication relating to third party tender offer
5:07pm
SC14D9C
8yrflkbc955lopu
18 Nov 21
Written communication relating to third party tender offer
3:18pm
8-K
nsj8ibezwc68nq
18 Nov 21
Novo Nordisk to Acquire Dicerna
8:31am
8-K
7ts woku9h3
9 Nov 21
Dicerna Announces Third Quarter 2021 Financial Results and Provides a Business Update
7:47am
8-K
ps4snt
9 Aug 21
Dicerna Announces Second Quarter 2021 Financial Results and Provides a Business Update
7:03am
8-K
zkaut06
6 Aug 21
Dicerna Reports Positive Top-Line Results From PHYOX™2 Pivotal Clinical Trial of Nedosiran for the Treatment of Primary Hyperoxaluria
9:01am
8-K
aauf5od8
4 Jun 21
Submission of Matters to a Vote of Security Holders
4:08pm
424B5
gkjdcc
6 May 21
Prospectus supplement for primary offering
5:12pm
8-K
i4gtpxm
6 May 21
Dicerna Announces First Quarter 2021 Financial Results and Provides a Business Update
4:14pm